Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 3
2005 3
2006 5
2007 5
2008 8
2009 4
2010 5
2011 6
2012 12
2013 22
2014 24
2015 20
2016 20
2017 16
2018 10
2019 14
2020 22
2021 23
2022 21
2023 21
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hyun h kim (200 results)?
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.
Kim HA, Lee JW, Nam SJ, Park BW, Im SA, Lee ES, Jung YS, Yoon JH, Kang SS, Lee SJ, Park KH, Jeong J, Cho SH, Kim SY, Kim LS, Moon BI, Lee MH, Kim TH, Park C, Jung SH, Gwak G, Kim J, Kang SH, Jin YW, Kim HJ, Han SH, Han W, Hur MH, Noh WC; Korean Breast Cancer Study Group. Kim HA, et al. J Clin Oncol. 2020 Feb 10;38(5):434-443. doi: 10.1200/JCO.19.00126. Epub 2019 Sep 16. J Clin Oncol. 2020. PMID: 31518174 Clinical Trial.
Drug-induced gynecomastia.
Bowman JD, Kim H, Bustamante JJ. Bowman JD, et al. Among authors: kim h. Pharmacotherapy. 2012 Dec;32(12):1123-40. doi: 10.1002/phar.1138. Epub 2012 Nov 16. Pharmacotherapy. 2012. PMID: 23165798 Review.
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
Baek SY, Noh WC, Ahn SH, Kim HA, Ryu JM, Kim SI, Lee EG, Im SA, Jung Y, Park MH, Park KH, Kang SH, Jeong J, Park E, Kim SY, Lee MH, Kim LS, Lim W, Kim S, Kim HJ. Baek SY, et al. J Clin Oncol. 2023 Nov 1;41(31):4864-4871. doi: 10.1200/JCO.23.00557. Epub 2023 Aug 22. J Clin Oncol. 2023. PMID: 37607321 Clinical Trial.
Breast Cancer Statistics in Korea, 2019.
Choi JE, Kim Z, Park CS, Park EH, Lee SB, Lee SK, Choi YJ, Han J, Jung KW, Kim HJ, Kim HA; Korean Breast Cancer Society. Choi JE, et al. J Breast Cancer. 2023 Jun;26(3):207-220. doi: 10.4048/jbc.2023.26.e27. J Breast Cancer. 2023. PMID: 37387348 Free PMC article. Review.
Prevalence and Risk Factors of Tamoxifen Retinopathy.
Kim HA, Lee S, Eah KS, Yoon YH. Kim HA, et al. Ophthalmology. 2020 Apr;127(4):555-557. doi: 10.1016/j.ophtha.2019.10.038. Epub 2019 Nov 7. Ophthalmology. 2020. PMID: 31813590 Free article. No abstract available.
Response to Letter by Dr. Cristina Brandolini.
Kim HA, Lee H. Kim HA, et al. J Stroke. 2017 May;19(2):244-245. doi: 10.5853/jos.2017.00773. Epub 2017 May 31. J Stroke. 2017. PMID: 28592780 Free PMC article. No abstract available.
229 results